Acrobiosystems Co.Ltd.
Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China.
Market Cap & Net Worth: Acrobiosystems Co.Ltd. (301080)
Acrobiosystems Co.Ltd. (SHE:301080) has a market capitalization of $996.26 Million (CN¥7.31 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #9967 globally and #2130 in its home market, demonstrating a -0.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Acrobiosystems Co.Ltd.'s stock price CN¥43.55 by its total outstanding shares 167848198 (167.85 Million).
Acrobiosystems Co.Ltd. Market Cap History: 2021 to 2026
Acrobiosystems Co.Ltd.'s market capitalization history from 2021 to 2026. Data shows change from $3.02 Billion to $996.26 Million (-18.20% CAGR).
Acrobiosystems Co.Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Acrobiosystems Co.Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.57x
Acrobiosystems Co.Ltd.'s market cap is 1.57 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
8.15x
Acrobiosystems Co.Ltd.'s market cap is 8.15 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $3.02 Billion | $384.99 Million | $174.21 Million | 7.85x | 17.35x |
| 2022 | $1.49 Billion | $474.43 Million | $203.73 Million | 3.14x | 7.30x |
| 2023 | $1.31 Billion | $543.65 Million | $153.59 Million | 2.42x | 8.55x |
| 2024 | $1.01 Billion | $645.02 Million | $123.83 Million | 1.57x | 8.15x |
Competitor Companies of 301080 by Market Capitalization
Companies near Acrobiosystems Co.Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Acrobiosystems Co.Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Acrobiosystems Co.Ltd. Historical Marketcap From 2021 to 2026
Between 2021 and today, Acrobiosystems Co.Ltd.'s market cap moved from $3.02 Billion to $ 996.26 Million, with a yearly change of -18.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥996.26 Million | -19.35% |
| 2025 | CN¥1.24 Billion | +22.34% |
| 2024 | CN¥1.01 Billion | -23.09% |
| 2023 | CN¥1.31 Billion | -11.73% |
| 2022 | CN¥1.49 Billion | -50.80% |
| 2021 | CN¥3.02 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Acrobiosystems Co.Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $996.26 Million USD |
| MoneyControl | $996.26 Million USD |
| MarketWatch | $996.26 Million USD |
| marketcap.company | $996.26 Million USD |
| Reuters | $996.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.